The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma

European Journal of Cardio-thoracic Surgery

Volumn 33, Issue 1, 2008, Pages 83-88

  Nakas, Apostolos ^a   Martin Ucar, Antonio E ^a   Edwards, John G ^a   Waller, David A ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Decortication; Mesothelioma; Pleurectomy; Pleuropneumonectomy; Surgery

Indexed keywords

CISPLATIN; PEMETREXED; RALTITREXED;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAPHRAGM; ECHOCARDIOGRAPHY; EXTRAPLEURAL PNEUMONECTOMY; FEMALE; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LENGTH OF STAY; LUNG FUNCTION TEST; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MESOTHELIOMA; MINIMALLY INVASIVE SURGERY; MONOTHERAPY; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIUM; PEROPERATIVE COMPLICATION; PLEURA CANCER; PLEURA MESOTHELIOMA; PLEURECTOMY; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; STERNOTOMY; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; SURVIVAL RATE; THORACOSCOPY; THORAX SURGERY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VIDEO ASSISTED THORACIC SURGERY; VIDEORECORDING;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MESOTHELIOMA; PLEURAL NEOPLASMS; PNEUMONECTOMY; THORACIC SURGERY, VIDEO-ASSISTED; TREATMENT OUTCOME;

EID: 37349130285     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.09.039     Document Type: Article

References (25)

1. Maziak D.E., Gagliardi A., Haynes A.E., Mackay J.A., Evans W.K., and Cancer Care Ontario Program in Evidence-based Care Lung Cancer Disease Site Group. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Lung Cancer 48 2 (2005) 157-169
2. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., Richards W.G., Strauss G.M., Corson J.M., DeCamp Jr. M.M., Swanson S.J., Bueno R., Lukanich J.M., Baldini E.H., and Mentzer S.J. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117 1 (1999) 54-63
3. Martin-Ucar A.E., Nakas A., Edwards J.G., and Waller D.A. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg 31 5 (2007) 765-770
4. Lee T.T., Everett D.L., Shu H.K., Jahan T.M., Roach III M., Speight J.L., Cameron R.B., Phillips T.L., Chan A., and Jablons D.M. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 124 6 (2002) 1183-1189
5. Waller D.A., Morritt G.N., and Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest 107 5 (1995) 1454-1456
6. Halstead J.C., Lim E., Venkateswaran R.M., Charman S.C., Goddard M., and Ritchie A.J. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Eur J Surg Oncol 31 3 (2005) 314-320
7. Edwards J.G., Abrams K.R., Leverment J.N., Spyt T.J., Waller D.A., and O'Byrne K.J. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 55 9 (2000) 731-735
8. Burgers J.A., and Damhuis R.A. Prognostic factors in malignant mesothelioma. Lung Cancer 45 Suppl. 1 (2004) S49-S54
9. Edwards J.G., Stewart D.J., Martin-Ucar A., Muller S., Richards C., and Waller D.A. The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma. J Thorac Cardiovasc Surg 131 5 (2006) 981-987
10. Aziz T., Jilaihawi A., and Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 22 2 (2002) 298-305
11. British Thoracic Society; Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 56 2 (2001) 89-108
12. Pilling J.E., Stewart D.J., Martin-Ucar A.E., Muller S., O'Byrne K.J., and Waller D.A. The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg 25 4 (2004) 497-501
13. Stewart D., Waller D., Edwards J., Jeyapalan K., and Entwisle J. Is there a role for pre-operative contrast-enhanced magnetic resonance imaging for radical surgery in malignant pleural mesothelioma?. Eur J Cardiothorac Surg 24 6 (2003) 1019-1024
14. Edwards J.G., Martin-Ucar A.E., Stewart D.J., and Waller D.A. Right extrapleural pneumonectomy for malignant mesothelioma via median sternotomy or thoracotomy? Short- and long-term results. Eur J Cardiothorac Surg 31 5 (2007) 759-764
15. Waller D.A., and Rengarajan A. Thoracoscopic decortication: a role for video-assisted surgery in chronic postpneumonic pleural empyema. Ann Thorac Surg 71 6 (2001) 1813-1816
16. Rusch V.W., and Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 111 4 (1996) 815-825
17. Rusch V.W., and Venkatraman E.S. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 68 5 (1999) 1799-1804
18. Soysal O., Karaoglanoglu N., Demiracan S., Topcu S., Tastepe I., Kaya S., Unlu M., and Cetin G. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg 11 2 (1997) 210-213
19. Martin-Ucar A.E., Edwards J.G., Rengajaran A., Muller S., and Waller D.A. Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. Eur J Cardiothorac Surg 20 6 (2001) 1117-1121
20. Lucchi M., Chella A., Melfi F., Dini P., Ambrogi M., Fino L., Fontanini G., and Mussi A. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma. Eur J Cardiothorac Surg 31 3 (2007) 529-533
21. Waller D.A. Malignant mesothelioma-British surgical strategies. Lung Cancer 45 Suppl. 1 (2004) S81-S84
22. Stewart D.J., Martin-Ucar A.E., Edwards J.G., West K., and Waller D.A. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations. Eur J Cardiothorac Surg 27 3 (2005) 373-378
23. Grossebner M.W., Arifi A.A., Goddard M., and Ritchie A.J. Mesothelioma-VATS biopsy and lung mobilization improves diagnosis and palliation. Eur J Cardiothorac Surg 16 6 (1999) 619-623
24. Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., Gatzemeier U., Boyer M., Emri S., Manegold C., Niyikiza C., and Paoletti P. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 14 (2003) 2636-2644
25. Bottomley A., Gaafar R., Manegold C., Burgers S., Coens C., Legrand C., Vincent M., Giaccone G., Van Meerbeeck J, EORTC Lung-Cancer Group; National Cancer Institute, and Canada. Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study. J Clin Oncol 24 9 (2006) 1435-1442